hoe 33342 has been researched along with Malignant Melanoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chanvorachote, P; Chaotham, C; Ninsontia, C; Pongjit, K | 1 |
Burns, PN; Foster, FS; Goertz, DE; Kerbel, RS; Yu, JL | 1 |
Burch, JA; Darrow, TL; Grichnik, JM; Liu, J; Schulteis, RD; Seigler, HF; Shan, S; Vervaert, CE | 1 |
Danoy, PA; Dong, Y; Dunn, IS; Jacobs, JJ; Kaushal, A; McGregor, K; Michel, J; Sturm, RA; Wong, SS; Zhang, XM | 1 |
Rofstad, EK; Tufto, I | 1 |
Carmeliet, P; Coomber, BL; Kerbel, RS; Nagy, A; Rak, JW; Yu, JL | 1 |
Baguley, BC; Finlay, GJ | 1 |
7 other study(ies) available for hoe 33342 and Malignant Melanoma
Article | Year |
---|---|
Silymarin selectively protects human renal cells from cisplatin-induced cell death.
Topics: Acute Kidney Injury; Antineoplastic Agents; Antioxidants; Apoptosis; Benzimidazoles; Cell Death; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Formazans; Humans; Kidney; Lung Neoplasms; Melanoma; Propidium; Protective Agents; Silybum marianum; Silymarin; Tetrazolium Salts; Tumor Cells, Cultured | 2011 |
High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Humans; Melanoma; Mice; Mice, Nude; Neovascularization, Pathologic; Organophosphorus Compounds; Staining and Labeling; Tumor Cells, Cultured; Ultrasonics; Ultrasonography; Xenograft Model Antitumor Assays | 2002 |
Melanoma, a tumor based on a mutant stem cell?
Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dendritic Cells; Fluorescent Dyes; gp100 Melanoma Antigen; Humans; Intermediate Filament Proteins; Melanoma; Membrane Glycoproteins; Mutation; Neoplasm Metastasis; Neoplasm Proteins; Neoplastic Stem Cells; Nerve Tissue Proteins; Nestin; Skin Neoplasms | 2006 |
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Topics: Base Sequence; Benzimidazoles; Bisbenzimidazole; Cell Cycle; Cell Differentiation; Cell Survival; Chromomycin A3; DNA-Binding Proteins; DNA, Neoplasm; HeLa Cells; Humans; Melanoma; Membrane Glycoproteins; Molecular Sequence Data; Monophenol Monooxygenase; Oxidoreductases; Promoter Regions, Genetic; Proteins; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
Transient perfusion in human melanoma xenografts.
Topics: Animals; Benzimidazoles; Carbocyanines; Cell Line; Fluorescent Dyes; Humans; Melanoma; Mice; Mice, Nude; Microcirculation; Perfusion; Staining and Labeling; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Heterogeneous vascular dependence of tumor cell populations.
Topics: Animals; Benzimidazoles; Blood Vessels; Cell Division; DNA-Binding Proteins; Fluorescent Dyes; Genotype; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Teratoma; Transcription Factors; Transplantation, Heterologous | 2001 |
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |